Background Chloroquine, a previous highly efficacious, easy to use and affordable anti-
malarial agent was withdrawn from malaria endemic regions due to high levels of …

Malaria is the world's most prevalent disease that affects 515-600 million people each year
and about 40% of the world's population live at risk for this infection. The prevalence of …

Background Drug resistance is one of the greatest challenges of malaria control
programmes, with the monitoring of parasite resistance to artemisinins or to Artemisinin …

Despite development of preventive and controlling strategies regarding infectious diseases,
they are still considered as one of the most significant leading causes of morbidity and …

Abstract Background In Pakistan, artesunate (AS) in combination with sulfadoxine–
pyrimethamine (SP) is the recommended treatment for uncomplicated Plasmodium …

Antimalarial chemotherapy is one of the main pillars in the prevention and control of malaria.
Following widespread resistance of Plasmodium falciparum to chloroquine, sulfadoxine …

Background: Anopheles fluviatilis, one of the major malaria vectors in Iran, is assumed to be
a complex of sibling species. The aim of this study was to evaluate Cytochrome oxidase I …

Background Despite evident success of malaria control in many sites in the Arabian
Peninsula, malaria remains endemic in a few spots, in Yemen and south-west of Saudi …

In Gabon, sulfadoxine‐pyrimethamine (SP) is recommended for intermittent preventive
treatment during pregnancy (IPTp‐SP) and for uncomplicated malaria treatment through …

In Iran, both Plasmodium vivax and P. falciparum malaria have been detected, but P. vivax is
the predominant species. Point mutations in dihydrofolate reductase (dhfr) gene in both …